Göteborg, Sweden

Ingegerd Adlerberth

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Location History:

  • Goteborg, SE (2000)
  • Göteborg, SE (2016)

Company Filing History:


Years Active: 2000-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ingegerd Adlerberth: Innovator in Veterinary Medicine

Introduction

Ingegerd Adlerberth is a notable inventor based in Göteborg, Sweden. She has made significant contributions to the field of veterinary medicine, particularly in the prevention of inflammatory disorders in domestic non-human mammals. With a total of 2 patents, her work has garnered attention for its innovative approach to animal health.

Latest Patents

Adlerberth's latest patents include a groundbreaking invention focused on the prevention of inflammatory disorders in domestic non-human mammals. This invention involves the use of a bacterial superantigen for administration onto the mucous membrane of these animals, aiming to prevent conditions such as allergies, autoimmune, and inflammatory diseases. Another notable patent is related to epithelial adhesive lactobacilli, which further showcases her commitment to advancing veterinary science.

Career Highlights

Throughout her career, Ingegerd Adlerberth has worked with prominent companies in the field, including Probi AB and Premune AB. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to the advancement of veterinary medicine.

Collaborations

Adlerberth has collaborated with esteemed colleagues, including Agnes Wold and Siv Ahrne. These partnerships have played a crucial role in her research and development efforts, enhancing the impact of her inventions.

Conclusion

Ingegerd Adlerberth stands out as a pioneering inventor in the realm of veterinary medicine. Her innovative patents and collaborations reflect her dedication to improving animal health and welfare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…